Characterization of Shigella sonnei in Malaysia, an increasingly prevalent etiologic agent of local shigellosis cases

BMC Infectious Diseases

Kwai Lin Thong³  Norazah Ahmad⁵  Haruo Watanabe¹  Noni Ajam⁴  Chien Shun Chiou²  Xiu Pei Koh³ 

[1] National Institute of Infectious Diseases, Tokyo, Japan;Central Region Laboratory, Center for Research and Diagnostics, Centers for Disease Control, Taichung City, 40855, Taiwan;Laboratory of Biomedical Science and Molecular Microbiology, Institute of Graduate Studies, University of Malaya, Kuala Lumpur, 50603, Malaysia;Institute of Biological Science, Faculty of Science, University of Malaya, Kuala Lumpur, 50603, Malaysia;Bacteriology Unit, Institute for Medical Research, Kuala Lumpur, Malaysia

关键词: Resistotype;    PFGE;    MLVA;    Diversity;    Biotype;    Shigella sonnei;   

Others  :  1175369
DOI  :  10.1186/1471-2334-12-122

 received in 2011-12-27, accepted in 2012-04-10,  发布年份 2012

【 摘 要 】

Background

Shigellosis is a major public health concern worldwide, especially in developing countries. It is an acute intestinal infection caused by bacteria of the genus Shigella, with a minimum infective dose as low as 10–100 bacterial cells. Increasing prevalence of Shigella sonnei as the etiologic agent of shigellosis in Malaysia has been reported. As there is limited information on the genetic background of S. sonnei in Malaysia, this study aimed to characterize Malaysian S. sonnei and to evaluate the prospect of using multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) for subtyping of local S. sonnei.

Methods

Forty non-repeat clinical strains of S. sonnei isolated during the years 1997–2000, and 2007–2009 were studied. The strains were isolated from stools of patients in different hospitals from different regions in Malaysia. These epidemiologically unrelated strains were characterized using biotyping, antimicrobial susceptibility testing, pulsed-field gel electrophoresis (PFGE) and MLVA.

Results

The two biotypes identified in this study were biotype a (n = 29, 73%) and biotype g (n = 11, 27%). All the 40 strains were sensitive to kanamycin, ceftriaxone and ciprofloxacin. Highest resistance rate was observed for streptomycin (67.5%), followed by tetracycline (40%) and trimethoprim-sulfamethoxazole (37.5%). All the S. sonnei biotype g strains had a core resistance type of streptomycin - trimethoprim-sulfamethoxazole - tetracycline whereas the 29 biotype a strains were subtyped into eight resistotypes. All the strains were equally distinguishable by PFGE and MLVA. Overall, PFGE analysis indicated that S. sonnei biotype a strains were genetically more diverse than biotype g strains. Cluster analysis by MLVA was better in grouping the strains according to biotypes, was reflective of the epidemiological information and was equally discriminative as PFGE.

Conclusions

The S. sonnei strains circulating in Malaysia throughout the period studied were derived from different clones given their heterogeneous nature. MLVA based on seven selected VNTR loci was rapid, reproducible and highly discriminative and therefore may complement PFGE for routine subtyping of S. sonnei.

【 授权许可】

   
2012 Koh et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Levinson W: Basic bacteriology & brief summaries of medically important organisms. In Medical Microbiology and Immunology: Examination and Board Review. Eighth edition. Edited by . The McGraw-Hill Companies, New York; 2004:30-476.
• [2]World Health Organization: Future needs and directions for Shigella vaccines. Wkly Epidemiol Rec 2006, 81:51-58.
• [3]Pichel M, Gonzalez Fraga S, Terragno R, Mulki J, Gentile A, Kremer C, Mola AM, Noseda R, Binsztein N: Short report: analysis of clonal relationship among Shigella sonnei isolates circulating in Argentina. Epidemiol Infect 2007, 135:681-687.
• [4]World Health Organization: Initiative for Vaccine Research (IVR): Diarrhoeal Diseases (Updated February 2009). Shigellosis. http://www.who.int/vaccine_research/diseases/diarrhoeal/en/index6.html webcite
• [5]Chompook P, Samosornsuk S, von Seidlein L, Jitsanguansuk S, Sirima N, Sudjai S, Mangjit P, Kim DR, Wheeler JG, Todd J: Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ 2005, 83(10):739-746.
• [6]Vinh H, Nhu NT, Nga TV, Duy PT, Campbell JI, Hoang NV, Boni MF, My PVT, Parry C, Nga TTT, Van Minh P, Thuy CT, Diep TS, Phuong LT, Chinh MT, Loan HT, Tham NTH, Lanh MN, Mong BL, Anh VTC, Bay PVB, Chau NVV, Farrar J, Baker S: A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 2009, 9:204. BioMed Central Full Text
• [7]Lee WS, Puthucheary SD: Species distribution and antibiotic resistance of Shigella isolates in an urban community in Malaysia. Med J Malaysia 2003, 58:262-267.
• [8]Banga Singh K-K, Ojha SC, Deris ZZ, Abdul Rahman R: A 9-year study of shigellosis in Northeast Malaysia: antimicrobial susceptibility and shifting species dominance. J Public Health 2011, 19:231-236.
• [9]Mammina C, Aleo A, Romani C, Nastasi A: Shigella sonnei biotype g carrying class 2 integrons in southern Italy: a retrospective typing study by pulsed field gel electrophoresis. BMC Infect Dis 2006, 6:117. BioMed Central Full Text
• [10]Ranjbar R, Aleo A, Giammanco GM, Dionisi AM, Sadeghifard N, Mammina C: Genetic relatedness among isolates of Shigella sonnei carrying class 2 integrons in Tehran, Iran, 2002–2003. BMC Infect Dis 2007, 22:62.
• [11]Van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, Fussing V, Greens J, Feil E, Gerner-Smidt P, Brisse S, Struelens M: Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007, 13(suppl 3):1-46.
• [12]Hoe CH, Yasin RM, Koh YT, Thong KL: Antimicrobial susceptibility and pulsed-field gel electrophoresis of Shigella sonnei strains in Malaysia (1997–2000). J Appl Microbiol 2005, 99:133-140.
• [13]DeLappe N, Doran G, Connor JO, Mammina C, Cormican M: Use of pulsed-field gel electrophoresis for comparison of similar but distinguishable isolates of Shigella sonnei collected in Ireland and Italy. J Clin Microbiol 2006, 44(10):3808-3810.
• [14]Izumiya H, Tada Y, Ito K, Morita-Ishihara T, Ohnishi M, Terajima J, Watanabe H: Characterization of Shigella sonnei isolates from travel associated cases in Japan. J Med Microbiol 2009, 58:1486-1491.
• [15]Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ: Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006, 3(1):59-67.
• [16]Chiou CS, Wei HL, Wang YW, Liao JC, Li CC: Usefulness of inter-IS1 spacer polymorphisms for subtyping of Shigella sonnei isolates. J Clin Microbiol 2006, 44:3928-3933.
• [17]Chiou CS, Watanabe H, Wang YW, Wang WL, Terajima J, Thong KL, Phung DC, Tung SK: Utility of multilocus variable-number tandem-repeat analysis as a molecular tool for phylogenetic analysis of Shigella sonnei. J Clin Microbiol 2009, 47:1149-1154.
• [18]Liang SY, Watanabe H, Terajima J, Li CC, Liao JC, Tung SK, Chiou CS: Multilocus variable-number tandem-repeat analysis for molecular typing of Shigella sonnei. J Clin Microbiol 2007, 45:3574-3580.
• [19]Nastasi A, Pignato S, Mammina C, Giammanco G: rRNA gene restriction patterns and biotypes of Shigella sonnei. Epidemiol Infect 1993, 110:23-30.
• [20]Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (Update). CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, Pennsylvannia; 2010.
• [21]Simpson EH: Measurement of species diversity. Nature 1949, 163:688.
• [22]Ekdahl K, Andersson Y: The epidemiology of travel-associated shigellosis-regional risks, seasonality and serogroups. J Infect 2005, 51:222-229.
• [23]Valcanis M: Laboratory testing of Shigella. In Victorian Infectious Diseases Bulletin. Volume 13 Issue 4. Edited by Clothier H, Rowe S, Easton M, McBryde E, Fielding J, Lester R. Health Protection Branch: Wellbeing, Integrated Care and Ageing, Victorian Government Department of Health, Lonsdale Street, Melbourne; 2010:114-118.
• [24]Seol SY, Kim YT, Jeong YS, Oh JY, Kang HY, Moon DC, Kim J, Lee YC, Cho KT, Lee JC: Molecular characterization of antimicrobial resistances in Shigella sonnei isolates in Korea. J Med Microbiol 2006, 55:871-877.
• [25]McIver CJ, White PA, Jones LA, Karagiannis T, Harkness J, Marriott D, Rawlinson WD: Epidemic strains of Shigella sonnei biotype g carrying integrons. J Clin Microbiol 2002, 40:1538-1540.
• [26]Mammina C, Pontello M, Dal Vecchio A, Nastasi A, Shigella sonnei Working Group: Identification of Shigella sonnei biotype g isolates carrying class 2 integrons in Italy (2001 to 2003). J Clin Microbiol 2005, 43:2467-2470.
• [27]Lee TS, Chang CY, Chang LL, Chen WM, Wang TK, Chang SF: One predominant type of genetically closely related Shigella sonnei prevalent in four sequential outbreaks in school children. Diagn Microbiol Infect Dis 2003, 45:173-181.
• [28]Ministry of Health: National Antibiotic Guideline 2008 (Updated 25 March 2009). http://www.pharmacy.gov.my/aeimages//File/National_Antibiotic_Guideline_2008_edit(2).pdf webcite
• [29]Filliol-Toutain I, Chiou C-S, Mammina C, Gerner-Smidt P, Thong K-L, Phung DC, Pichel M, Ranjbar R, Gassama Sow A, Cooper K, Ribot E, Binsztein N, Liang S-Y: Global distribution of Shigella sonnei clones. Emerg Infect Dis2011 Oct [cited 2011 Oct 1]. Available fromhttp://wwwnc.cdc.gov/eid/article/17/10/pdfs/10-1486.pdf webcite